ArticleBiotechnology reports (Amsterdam, Netherlands)2025
The interplay of serum cations, insulin resistance, and atherogenic indices in predicting depression in hypothyroid patients.
Article in Biotechnology reports (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A significant proportion of people with hypothyroidism (HT) is linked to affective disorders, including depression. The pathophysiology and factors affecting or predicating depression in HT patients is still to be elucidated. The current study intends to investigate serum levels of cations, insulin resistance parameters, trace elements and atherogenic indices, in HT+Dep, HT, and healthy control groups. Methods: We measured the biomarkers in the blood of sixty HT+Dep patients, sixty HT patients, and healthy controls who participated in the study. Selenium was measured using flameless atomic absorption spectrophotometry. While insulin level was measured using the ELISA technique. Results: We observed significant insulin resistance (IR) and dyslipidemia in HT patients, which were more pronounced in HT+Dep. Moreover, HT+Dep patients exhibited alterations in the blood concentrations of cations and trace elements. Artificial neural network analysis demonstrated that the atherogenic index of plasma (AIP) is the most precise predictor of depression in HT patients, with a success rate of 100%. This was followed by the distance from Castelli's risk index-I (CRI-I) (24.7%), ionized calcium (23.1%), the IR index (HOMA2IR) (22.4%), and the insulin sensitivity index (HOMA2S%) (21.8%). Selenium, conversely, was the most reliable biomarker for differentiating the HT group from the control group. Conclusion: Depression in HT patients is associated with alteration in the serum levels of cations, atherogenic indices, trace elements, and IR. AIP is the best predictor for depression in HT patients. It is essential to correct the amounts of blood biomarkers of HT patients to mitigate the severity of depression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.